Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: Mr.Manners who wrote (1189)	7/20/1998 11:24:00 AM
From: Dave Gore	Read Replies (1) \| Respond to of 4028

KASHA: Again you miss the point.... Would anyone have attacked Janice if SHE had not invaded the SGNC thread? Again, people get angry when people who invade their stock thread and spread fear and doubt with no proof. My God, why are you guys bashing a stock like SGNC and CYGS...can you find no more suitable stocks to slam? There are hundreds of companies that probably ARE scams...go after them. But why pick do your friends picks on SGNC or CYGS or DGIV....are they really the worst companies out there? That is why people don't trust you and your friends. You pick on stocks that are not scams PASADENA, Calif.--(BUSINESS WIRE)--June 18, 1998--Sanguine Corp. (OTC BB:SGNC) and Battelle Memorial Research Institute Thursday announced that a completed contract has been signed and that the funding is now in place for animal testing of emulsions for use as oxygen-carrying blood substitutes. Battelle, the world's oldest and largest independent contract research group of scientists, engineers, and other specialists, has provided research since 1994 in support of Sanguine's efforts to develop, manufacture and market a proprietary synthetic red blood cell substitute.